NCT05520125

Treatment of Patients With Bone Tissue Defects Using Mesenchymal Stem Cells Enriched by Extracellular Vesicles

Treatment of Patients With Segmental Bone Tissue Defects Using Mesenchymal Stem Cells Enriched by Extracellular Vesicles

• Status: Unknown
• Phase: Phase 1 / Phase 2
• Study type: Interventional
• Enrollment: 20 (estimated)
• Sponsor: Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus · Other Government
• Sex: All
• Age: 18 Years – 50 Years
• Healthy volunteers: Not accepted

Summary

Treatment of patients with segmental bone tissue defects using mesenchymal stem cells enriched by extracellular vesicles

Detailed description

The aims of the project are to develop a technology for obtaining mesenchymal stem cells extracellular vesicles; to develop biomedical cell product based on mesenchymal stem cells enriched with own extracellular vesicles; to conduct the clinical trials of the biomedical cell product in the treatment of patients with segmental bone tissue defects

Conditions

• Segmental Fracture - Bone Loss

Interventions

Type	Name	Description
BIOLOGICAL	Mesenchymal stem cells enriched by extracellular vesicles	Mesenchymal stem cells enriched by extracellular vesicles
OTHER	Standard treatment of bone defects	Standard surgical treatment of bone defects

Timeline

• Start date: 2022-11-01
• Primary completion: 2023-12-31
• Completion: 2023-12-31
• First posted: 2022-08-29
• Last updated: 2022-08-29

Locations

1 site across 1 country: Belarus